During the 1991 Persian Gulf War several US military personnel were wounded by shrapnel fragments consisting of depleted uranium. These fragments were treated as conventional shrapnel and were not surgically removed to spare excessive tissue damage. Uranium bioassays conducted over a year after the initial uranium injury indicated a significant increase in urine uranium levels above natural background levels. The potential' mutagenic effects 'of depleted uranium ate'unknown. To assess the potential mutagenic effects of-long-term exposure'to internalized depleted uranium,' Sprague-Dawley'rats 'were implanted with depleted uranium and their urine and serum were evaluated 'for mutagenic potential at various times after pellet implantation using the 'Ames Salmonella 'reversion .,ssay.'Tantalum, an inert metal widely used in prosthetic' devices was used for comparison.'Enhancement of muta-"\-.genic actitity in' Salmonella typhiurium strain TA98'and the Ames [ITH mixed strains (TA7001-7006) was observed in urine samples from'animals implanted'with depleted' uranium pellets. In' contrast,'urine samples frtom animals implanted with tantalum did not show a significant enhancement of mutagenic activity in 'these strains. Indepleted uranium-implanted animals, urine niutagenicity increased in a 'dose-and time-dependent manner demonstraling a strong positive correlation with urine uranium levels (r = 0.995, 'P <-0.001). There was no mutagenic enhancement of any bacterial strain' detected in the;sera of animals implanted' with' either depleted urantium or tantalum pellets; The results suggest that uranium content in the urine is correlated with 'urine mutagenicity and that urinary:rutagenicity might 'be used as a'biomarker to detect exposure to'inte'rnalized uranium. uranium consists of three isotopes.
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2 38 U (99.276%') , 'u (0.718%) and 2 34U (0.0056%), and during the enrichment process two products are produced, enriched uranium and DU, which contain different relative ratios of the three isotopes. The resultant DU contains 238 U '(99.8%), 2351U (0.20%) and 234 U (0.001%). DU is therefore -60% as radioactive as naturally occurring uranium, since it has essentially been depleted of' 235 J and 234U. As a result, the specific activity of DU is significantly less than natural uranium (0.4 versus 0.7 pCi/g, respectively).
-- ' l DU internalization, in 'contrast to occupational uranium exposure, presents a unique toxicological problem, because it combines chemical toxicity with radiological exposure. While reports have linked occupational uranium exposure to lung carcinogenesis, it is believed that this is due to inhalation of -the uranium decay product radon gas and the chemical toxicity of uranium is not involved (National Research Council Committee on the Biological Effects'of Ionizing Radiation, 1988; Vahakangas et al., 1992) . Therefore, limited data exist to permit an accurate assessment of health risks from embedded DU fragments. Furthermore, the chemical toxicity of acute,' short-term exposures to uranium has clearly been demonstrated in animals and humans (Wrenn et al., 1985 (Wrenn et al., , 1990 , while the long-term health risks associated with chronic internal exposure are not as well defined (National Research Council Committee on the Biological Effects of Ionizing Radiation'. 1988). In view of medical 'management questions relevant to current and possible future incidents'of DU internalization, examination. of potential mutagenic effects of DU internalization are critical and will assist in an understanding of the etiology of potential disease development.
The goal of the current study was to conduct mutagenicity testing of the urine 'and serum samples obtained from rats implanted with either DU 'or tantalujm pellets using the Ames reversion assay. We wanted to determine if there was a timeor metal dose-dependent relationship. to'urine mutagenicity. *Additiorially,'we wanted to"evaluate the'relationship between urine uranium levels'and mutagenic potential. The data strongly'-indicate that urine mutagenicity is correlated with increased urine uranium content. 'The implications of these results to the 'development of a monitoring program designed to' assess the ' health effects of chronic exposure to internalized DU in humans is discussed. Introduction Several US military personnel participating in Operation Desert' Storm were wounded in friendly fire accidents and have Materials and methods retained large fragments of the radioactive 'metal depleted 
Pellet imptlatration surgery
The DU and Ta. pellets were cleaned and chemically sterilized prior to implantation. Pellets vwere immersed in industrial detergent. rinsed in absolute alcohol, soaked in 50% nitric acid solution for 3 min and then rinsed with sterile water. Animals were anesthetized with ketanine hydrochloride 180 mg/ kg) in combination with xylazine hydrochloride (4 mglkg). given i p. Fragments were implanted within the gastrocnemius muscle and were spaced -8-10 mm apart on the lateral side of each leg. Prior to surgery, the surgical sites were shaved and cleansed with betadine. Scalpel incisions were made through the skin and pellets were inserted into the muscle with a 16 gauge needle with plunger. Incisions were closed with absorbable sutures and surgical cement. Rats were closely monitored following surgery until they were ambulatory. The surgical sites were regularly examined by a veterinarian for signs of inflammation, infection and local DU toxicity, Urine and serum sample preparation Urine and serum samples were collected from different populations of rats at 6. 12 and 1S months after pellet implantation. Rais were placed individually in metabolic cages for 24 h to collect the urine. The 24 h urine collection sample was obtained from each rat and the volume recorded (10-20 ml). Four milliliters of the urine collected from each individual animal were set aside for urine mutagenicity testing: the reminder was used for uranium and chemical analysis. Urine uranium content was analyzed by Batelle (Pacific Northwest Laboratory). Urine wias filtered to remove any debris and frozen until analysis Frozen urine for mutagenicity testing was thawed and the urine from 8 animals/treatment group was combined to make a total volume of 32 ml urine/ treatment group. Filtered urine was passed over chromatographie columns containing Amberlite XAD-4 resin. The effluents were collected and passed through a column packed with Amberlite XAD-S resin. Resins were purified by Soshlet extraction before use. Use of these columns allowed the collection of a hyrdrophobic urine fraction IXAD-4) and a hydrophilic fraction (XAD8t. Furthermore. preliminary tests, indicated that use of either CIS resin or cyanopropyl columns resulted in an 18 or 15So reduction in mass recovery. respectively (data not shown). The column was successively washed with 10 ml distilled water and cluted with acetone. The dry extracts were dissolved in DMISO (320 pl). This process resulted in a IIXJx concentrate.
For the serum mutagenicity studies. 8 rats/treatment group w.ere used. At the designated titne intervals (6. 12 and 1 months), the animals were killed and blood was obtained from the aorta. Serum was separated by centrifugation IS oin at 30)0 gi and was vacuum dialyzcd through a dialysis tube with a cut-off salue of 30.0() IMiller et al.. 1993 : Szucs et cl.. 1994 .
Ames Surronella rer ersiorr assay
To assess urine and serum mutagenicity. the Salnonella bacterial reversion assay. developed by Mlarort and Ames t1983). was used. Specifically. the Ames llt'ri mutagenicity assay from Xenomnetrix allowed rapid assessment of the mutagenic potential of the urine and serum samples. The two strains used were the Ames IT"'> mixed strains and the frameshilft tester strain TA98. AmestlI" mixed strains contains equil numbers of the cells of each of six strains (TA700I-7t0fJ6i. Individually. these strains revert by only one specific base pair sub'titution out of six possible chances. Therefore. when mixed, all six base substitution mutations can be represented in one cultume IGee et ai. Frozen urine and serum samples were shipped oveinight on dry ice to Battelle Pacific Northwest Laboratoties for analysis of uranium content. Samples were prepared by wct ashing and were analyzed with a Kinetic Phosphorescence analyzer (KPA-ll; Chemchek Instruments Inc.. Richland. WA) (Brina and Miller. 1992) . Calibration curves were established prior-to sample analysis: measurements included analysis of relative standard deviations and correlation coefficients of the luminescence decay curve.
Results
A significant elevation in. mutagenic potential was observed with the XAD-4 and XAD-8 fractions of urine that was dependent on both the length of time and number of DU pellets implanted. Figure IA shows that the XAD-4 fraction of urine collected from rats implanted with DU pellets induced a significant increase in the revertant number of the TA98 strain at each assessment point (6, 12 and 18 months). The mutagenic potential showed a steady increase through the first 12 months after DU pellet implantation for animals with 4, 10. or 20 DU pellets.. At 18 months, however, the XAD-4 urine fraction from animals with the highest dose of DU implanted (20 DU pellets) resulted in a revertant number that was not statistically different from the number seen at 12 months in animals with 20 DU pellets (12 months. 287 _ 42.revertants/ pmol creatinine versus 18 months, 390 ± 91 revertants/pmolcreatinine). In contrast to the DU-implanted rats, the animals that had no or. tantalum implants did not demonstrate any increase in the mutation vield of strain TA98. Results with the XAD-8 urine concentrate indicated that animals implanted with either 10 or 20 DU pellets exhibited a statistically significant increase (P < 0.01) in mutagenic potential at 12 and 18 months after pellet implantationin comparison with animals with no or tantalum implants at those same time periods. No significant increase in mutagenicity of the XAD-8 fraction was observed in animals with the lowest, number of DU pellets (4) or in those with tantalum implants using strain TA98 at any of the time periods. Statitical analysis revealed that there was no significant difference between the number of revertants at 12 and 18 months in animals with either 10 or 20 DU pellets.
The mutagenic potential of both the XAD-4 and XAD-8 fractions was also examined using the Ames IlIT1 mixed strains (TA7001-TA7006). Both urine fractions showked a significant increase in mutagenic activity that was dependent on time and DU pellet number (Table 1 ). The mutagenic activity of the XAD-4 fraction from DU-implanted animals exhibited variable elevation at 6 ntonths after pellet implantation. However. there was a significant inciease in the mutagenicitv of the XAD-4 fraction at 12 and 18 months that was both time-and DU dose-dependent in comparison with animals with no or tantalum implants. Statistical analysis demonstrated that at 18 months, however. the XAD.4 urine fraction from animals with any dose of Dl' implanted (4, 10 or 20 Dl' pellets) resulted in a revertant number that was not statstically different from the Using a urine i extract dose of I ml equivalent/platc. the number of revertants/plate was determined. Mutagenicity data were calculated after adjustment for urinary creatinine concentrations. At each time point, the bars that are statistically different from the no implant controls at that time point are marked with an asterisk (P < 0.05 using Student's 1-test).
I.. pellets: tantalum. 20 pellets. cUsing a urine extract dose of I ml equivalent/plate, the number of revertants/plate was determined. NMutagenicity data were calculated after adjustment for urinary creatinine concentratiorts. dStatistically significant from animals with no implants assessed at the same time period (P < 0.05);
I'
revertant number seen at 12 months (Table 1) . For example, with 20 DU pellets (12,monihs,' 36.7 ± 3.5 revertan'ts/lmol creatinine 'versus 18 mronths,'39.2 ± 8.7 revertants/pimol creatinine). In contrast,. the XAD-8 fraction demonstrated 'a rapid increase in mutagenic potential, with animals implanted with the lowest number, of DU pellets (4) even'showing'a significant increase, in revertant colonies 6 months after pellet <by implantation: Similar to the results with the TA98 strain,'urine from non-surgical control animals or from those with tantalum implants did not exhibit any significant increase in mutagenicity. Again, the number of revertants appeared to plateau at 12 months, since the number of revertants at 18 months showed no statistically significant increase from the number observed at 12 months for all doses of DU. In contrast to the results obtained with urine from DUimplanted animals, the sera from these animals did not demonstrate any enhancement of the mutation' yield in the TA98 strain nor in'the mixed strains (TA7001-7006) (Table II) . Similarly, the sera from non-surgical control animals and from those with tantalum implants did not exhibit any alteration in mutagenic potential.
Urine and serum' were analyzed for uranium content. The data in Table III illustrate that animals implanted with DU pellets exhibited both a time-and dose-dependent increase in urine uranium levels up to 12 months after pellet implantation. At 18 months, however, the urine uranium levels either d-creased (4 and 20 pellet groups) in comparison with the levels at 12 months or remained the same (10 pellet group). Non-surgical controls or tantalum-implanted animals did not demonstrate any significant change in their urine uranium levels at the same time points (Table III) . To determine what. if any. effect the urine fractionation/chromratographic process had on the urine uranium content, the eluates were analyzed for uranium content. Data demonstrated that the hydrophobic (XAD-4) and hydrophilic (XAD-8) fractions contained 42 + 4% and 58 + 6% of the total unfractionated urine uranium, respectively. These data suggest that very. little uranium was lost during the urine fractionation' process.
In contrast to the urine analysis, serum uranium analysis demonstrated that the content of uranium in the serum of the DU-implanted animals 'was not significantly altered from controls at 6. 12-or 18 months after pellet implantation (data not shown).
The correlation between the urine uranium levels and urine mutagenicity was evaluated using urine (XAD-8 fraction, tested with the Ames II mixed strains) obtained from animals implanted with DU (4, 10 or 20 pellets) or tantalum for 12 months. A strong positive correlation was' obtained between urinary mutagenicity and urine uranium content, as seen in Figure 2 (Pearson r = 0.995, P < 0.001) for measurements made using urine obtained from animals 12 months after pellet implantation. A similar correlation analysis was done with urine uranium levels and urine muiagenicity from animals at 6 and 18 months after pellet implantation (data not shown).
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.C.Miller et al. Table 11 . Mutagenicity of serum samples from DU-or tantalum-implanted animals: number of revertant colonies/ml serum using strain TA98 or Ames 0nt mixed strains' Time (months) Dnseb Mutagenicity (revertants/ml serum) Strain TA98' Mixed strainsd 0 None 45 + 4 11.2 ± 1.2 Tantalum 43 _ 4 11.5 = 1.0 DU low 46 ± 5 13.2 ± 1.4 DU medium 47 t 4 11.2 _ 1.2 DU high 44 ± 5 11.9 ± 1.0 6 None 43 ± 5 11.5 ± 1.1 Tantalum 52 -6 10.5 ± 1.2 DU low 49 ± 5 10.7 ± 1.0 DU medium 60 ± 13 12.9 = 1.2 DU high 43 ± 4 11.6 ± 9.0 12 None 49 ± 5 13.4 ± 1.5 Tantalum 51 ± 6 12.0 ± 1.2 DU low 55 ± 6 10.9 1.5 DU medium 49 ± 4 11.1 _ 9.0 DU high 60± 9 13.5 ± 2.0 18 None 55 ± 6 11.8 5 1.4 Tantalum 59 ± 8 11.9 ± 1.4 DU low 57 ± 7 12.2 ± 1.0 DU medium 56 ± 6 14.2 = 1.9 DU high 42 ± 8 12.1 ± 1.1 'Ames nTm mixed strains contains an equimolar mixture of strains TA7001-TA7006. For a complete description of strain genotype see Gee et al. (1994) . bDose of metal: DU low. 4 pellets; DU medium. 10 pellets; DU high, 20 pellets: tantalum. 20 pellets. 'Using a serum dose of.l mtplate, the number of strain TA98 reversants/ plate/ml serum was determined. dUsing a serum dose of I mI/plate, the number of Ames llTM nuxed strain reverants/plate/ml serum was determined. Urine uranium content in ng/lmol creatinine. 'Statistically significant from control levels in animals with no implants (P < 0.05).
Similar to that observed at 12 months, a positive correlation was found between urinary muiagenicity and urine uranium content for 6 and 18 month data (6 months, Pearson r = 0.934, P < 0.001; 18 months, Pearson r = 0.83, P < 0.001). This analysis strongly argues that the uranium-associated Fig. 2 . Correlation (Pearson r) between urinary mutagenicity (revertants/ pmol creatinine) and urinary content of uranium (ng/jsmol creatinine) of animals implanted with either low. medium or high doses of DU. tantalum or no implant (n = 40. 8 per group) at 12 months. Mutagenicity data were calculated after adjustment for urinary creatinine levels. Correlation between uranium and mutagenicity values was calculated using Pearson's correlation test.
urinary mutagenesis was due to the presence of uranium in the urine.
Discussion
Several US soldiers were wounded by shrapnel fragments consisting of DU during the 1991 Gulf War. Uranium bioassays conducted over a vear after the initial uranium injury indicated *the presence of uranium in the urine in excess of natural background at up to 50 pg U/I urine; the natural background uranium urine excretion rate is typically 0.6 pg/day (US Army Environmental Policy Institute, 1995) . Although the soldiers with the embedded DU fragments had urine uranium levels well above background a year after the initial uranium injury, threshold toxic uranium urine excretion rates are typically 1000 pg/day (National Research Council Committee on the Biological Effects of Ionizing Radiation, 1989), which is significantly higher than the injured soldiers' 1 year levels. The Department of Veterans Affairs is monitoring these soldiers in a follow-up study to assess their current urine uranium levels.
Studies of the long-term health consequences of other forms of uranium, e.g. natural uranium, and types of exposure, e.g. inhalation, have demonstrated that uranium exposure is linked to lung carcinogenesis (Vahakangas et al., 1992; Jostes, 1996) . However, embedded DU fragments present a radiologically. and toxicologically unique situation with unknown health risks and there is limited information regarding its mutagenic or carcinogenic potential. Furthermore, urinary mutagenicity has been widely used as a general biomarker of exposure to genotoxic agents and may be an effective tool to complement human population monitoring of individuals exposed to DU.
This study was conducted to determine if the urine and/or serum of rats implanted with DU pellets was, mutagenic. The data demonstrate that with increasing urine uranium content, urine mutagenicity increased. Urine from rats implanted with a greater number of DUI pellets had greater amou'rnts of tranium and greater mutagenic potential, suggesting that uranium' in the urine was at least one of the potential mutagenic components of the urine tested. Both the uranium levels and mutagenicity steadily increased between 0 and 12 months, indicating the time dependence of this increase in urine mutagenic potential. 
'I
Even the lowest number of implanted DU pellets resulted in mutagenic urine as the pellet exposure time increased. At 18 months both uranium content and mutagenicity leveled off or decreased, further arguing for this correlation. This association <-~1is additionally supported by the similar analysis of serum samples. They did not contain increased levels of uranium nor did they demonstrate any mutagenic activity, indicating that there were very low serum levels of the mutagenic substance(s). The mutagenicity pattern indicates that both the hydrophobic (XAD4) and hydrophilic (XAD-8) fractions from DUimplanted animals contain both frameshift and base pair substitution mutagens to varying extents, depending upon the length of time after implantation and the number of DU pellets implanted. The high chemical reactivity of uranium in biological fluids is well known. It has been shown to complex with a variety of substances such as carbonates, proteins, minerals and phospholipids (Dounce and Flagg, 1949; Neuman and Tishkoff, 1953; Blake et al., 1956; Cooke and Holt, 1974; Schullery and Miller, 1977) . The ability of specific bacteria such as Escherichia coli and Citrobacter spp. to accumulate uranium from solution has also been observed (Macaskie et al., 1992) . Therefore. it is possible to speculate that uranium, possibly complexed with substances found in either the hydrophobic and hydrophilic fractions of the urine, causes an increase in mutagenic potential.
The strong positive relationship between urine uranium levels and mutagenicity argues that urine uranium may be the substance primarily responsible for the urine mutagenicity. However, other factors can affect mutagenicity and urine analysis. The measurement of both urine uranium and mutagenic potential, particularly at the 18 month time point, could have been affected by the advanced age of the animals tested (21 months old). Aging has been shown to be causally related to both renal dysfunction (Li et al., 1996) and increased mutagenicity in humans (Scarlett et al., 1990) . The urine mutagenicity of control animals (both non-surgical and Taimplanted), however, did not exhibit significant differences :
with advanced age. Another consideration is the potential nephroloxicity of the implanted DU. It is possible that cellular changes in the kidney resulting from DU exposure could affect interpretation of the results. It is important to note, however. that preliminary histological assessment of the kidney revealed no abnormal pathology or precancerous lesions (unpublished observations): Our report is the first showing that internalized DU can result in a significant enhancement of urinary mutagenicity. This is markedly different from other studies showing that high specific activity uranium exposure in vitro is mutagenic [using several mutagenicity assays including the Ames test and the HPRTT lymphocyte cloning assay (Roos et al., 1988;  i Baltschulkat and Horneck, 1991: Metting et al., 1992) ]. As discussed previously, occupational exposure of uranium miners to the uranium decay product radon has not only been linked to lung carcino-enesis, but to mutagenicity (Sram et al., 1993; Hussain et al., 1997) . While the presence of other potential genotoxic agents in the urine cannot be ruled out, the lack of imutagenic potential of the urine from animals with tantalum implants or those without any metal implants strongly suggests that the uranium is potentially responsible for the urine A_> mutagenicity. Additionally, the low uranium content of the serum, concomitant with the lack of serum niutagenicity. further argues that uranium is one of the mutagenic components in the urine. Other studies are needed to definitively determine what other substances in the urine of the animals with implanted DU are potentially responsible for the urinary mutagenicity observed here. Urinary mutagenicity has been used as a biomarker as an integral component of human population monitoring and disease epidemiology (DeMarini et al., .1997) .' Its effectiveness as a biomarker for genotoxic exposure has been demonstrated among people who smoke cigarettes (Yamasaki and Ames, 1977) , were exposed to antineoplastic drugs (Falck et atl. 1979; Nguyen el al., 1982) or were occupationtally exposed to chemicals (Dolara et-al., 1981) or to sewage (Scarlett-Kranz et al.. 1986) . Despite its inability to' identify the specific mutagen(s) in the urine, urine mutagenicity testing is a costeffective, general biomarker of exposure 'to' genotoxic agents. Our data suggest that this type of biomarker analysis might also be an effective tool in a program, designed to'assess the health effects of'chronic exposure to intemnaliied DU in humans.
